NO950564L - Substituerte cykloheksanolestere, deres anvendelse for behandling av sykdommer og farmasöytiske preparater - Google Patents

Substituerte cykloheksanolestere, deres anvendelse for behandling av sykdommer og farmasöytiske preparater

Info

Publication number
NO950564L
NO950564L NO950564A NO950564A NO950564L NO 950564 L NO950564 L NO 950564L NO 950564 A NO950564 A NO 950564A NO 950564 A NO950564 A NO 950564A NO 950564 L NO950564 L NO 950564L
Authority
NO
Norway
Prior art keywords
opt
diseases
treatment
substd
pharmaceutical preparations
Prior art date
Application number
NO950564A
Other languages
English (en)
Other versions
NO950564D0 (no
NO305754B1 (no
Inventor
Horst Hemmerle
Gerrit Schubert
Peter Below
Andreas Herling
Hans-Jorg Burger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO950564D0 publication Critical patent/NO950564D0/no
Publication of NO950564L publication Critical patent/NO950564L/no
Publication of NO305754B1 publication Critical patent/NO305754B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO950564A 1994-02-16 1995-02-15 Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende esterene NO305754B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4404848A DE4404848A1 (de) 1994-02-16 1994-02-16 Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate

Publications (3)

Publication Number Publication Date
NO950564D0 NO950564D0 (no) 1995-02-15
NO950564L true NO950564L (no) 1995-08-17
NO305754B1 NO305754B1 (no) 1999-07-19

Family

ID=6510346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950564A NO305754B1 (no) 1994-02-16 1995-02-15 Substituerte cykloheksanolestere, deres anvendelse ved fremstilling av preparater for behandling av sykdommer samt farmas°ytiske preparater inneholdende esterene

Country Status (21)

Country Link
US (3) US5567725A (no)
EP (1) EP0672660B1 (no)
JP (1) JPH07258220A (no)
KR (1) KR100360128B1 (no)
CN (1) CN1051298C (no)
AT (1) ATE309222T1 (no)
AU (1) AU679305B2 (no)
CA (1) CA2142556A1 (no)
CZ (1) CZ290065B6 (no)
DE (2) DE4404848A1 (no)
ES (1) ES2250966T3 (no)
FI (1) FI950649L (no)
HU (1) HUT73631A (no)
IL (1) IL112655A (no)
NO (1) NO305754B1 (no)
NZ (1) NZ270490A (no)
PL (1) PL178970B1 (no)
RU (1) RU2135465C1 (no)
SG (1) SG46690A1 (no)
TW (1) TW295578B (no)
ZA (1) ZA951220B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100566175B1 (ko) * 2000-08-16 2006-03-29 에프. 호프만-라 로슈 아게 신규한 아미노사이클로헥산 유도체
US6890915B2 (en) * 2001-05-25 2005-05-10 Bristol-Myers Squibb Pharma Company Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
AU2013363398B2 (en) 2012-12-20 2017-06-01 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
US9776976B2 (en) 2013-09-06 2017-10-03 Inception 2, Inc. Triazolone compounds and uses thereof
CN119735636A (zh) * 2024-09-06 2025-04-01 五邑大学 一种四环肽中间体化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440117A1 (de) * 1984-11-02 1986-05-15 Bayer Ag, 5090 Leverkusen Substituierte azolylcyclopropyl-azolylmethyl-carbinol-derivate
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
US5015653A (en) * 1989-07-10 1991-05-14 Hoffmann-La Roche Inc. [(5-oxo)-2-pyrrolidinyl)methyl]cyclohexaneacetamides, compositions and use
DE4202184A1 (de) * 1992-01-28 1993-07-29 Hoechst Ag Substituierte salicylaldehyde zur behandlung von krankheiten
TW255880B (no) * 1992-09-09 1995-09-01 Hoechst Ag
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases

Also Published As

Publication number Publication date
US5567725A (en) 1996-10-22
RU2135465C1 (ru) 1999-08-27
EP0672660B1 (de) 2005-11-09
US5719170A (en) 1998-02-17
EP0672660A2 (de) 1995-09-20
HU9500456D0 (en) 1995-03-28
PL307284A1 (en) 1995-08-21
US5629311A (en) 1997-05-13
ES2250966T3 (es) 2006-04-16
AU1225595A (en) 1995-08-24
CZ290065B6 (cs) 2002-05-15
IL112655A (en) 2003-05-29
PL178970B1 (pl) 2000-07-31
NZ270490A (en) 1996-02-27
FI950649A7 (fi) 1995-08-17
KR950032136A (ko) 1995-12-20
HUT73631A (en) 1996-08-28
ZA951220B (en) 1995-10-11
ATE309222T1 (de) 2005-11-15
FI950649A0 (fi) 1995-02-14
CN1051298C (zh) 2000-04-12
SG46690A1 (en) 1998-02-20
RU95101840A (ru) 1996-12-10
CN1126198A (zh) 1996-07-10
TW295578B (no) 1997-01-11
NO950564D0 (no) 1995-02-15
EP0672660A3 (de) 1997-05-28
CZ37995A3 (en) 1995-09-13
CA2142556A1 (en) 1995-08-17
NO305754B1 (no) 1999-07-19
AU679305B2 (en) 1997-06-26
JPH07258220A (ja) 1995-10-09
IL112655A0 (en) 1995-05-26
FI950649L (fi) 1995-08-17
DE4404848A1 (de) 1995-08-17
KR100360128B1 (ko) 2003-04-26
DE59511025D1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
ES2123287T3 (es) Derivados 3-benzoil benzofuranicos como antagonistas de la hormona tiroidea.
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
EP0349949A3 (en) Benzodiazepine derivatives
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES2167720T3 (es) Compuestos de 1-fenilpirazol y aplicaciones medicinales de los mismos.
CO4410329A1 (es) Nuevos pirrolocarbazoles
NO178261C (no) Substituerte diaminoftalimider og analoger, farmasöytiske preparater inneholdende dem samt deres anvendelse i medikamenter
NO950564L (no) Substituerte cykloheksanolestere, deres anvendelse for behandling av sykdommer og farmasöytiske preparater
DE69330601D1 (de) Serotoninergische ergolin derivate
NO973342L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.
NO308852B1 (no) Indol-2,3-dion-3-oksim-derivater, farmasøytisk blanding og anvendelse av forbindelsen
DK148288A (da) N-phenethylaminoalkyl-benzamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende forbindelserne
NO179472C (no) Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene
ES2152564T3 (es) Procedimientos e intermedios para preparar 3-(1-piperazinil)-1,2-benzoisotiazol.
HUT76480A (en) Alkyl-5-methyl-sulphonyl-benzoyl-guanidine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
NO930452D0 (no) Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol
ES8404343A1 (es) Un procedimiento para la prepracion de nuevos derivados de 1,4-diaminociclitol.
NO952194L (no) Spirofuranonderivater og deres anvendelse ved behandling av neurodegenerative sykdommer
DE69312322D1 (de) Cephem verbindungen mit antimicrobizide eigenschaften
RU94038051A (ru) Гетероциклические производные, способ их получения, фармацевтическая композиция и способ лечения
IT1241928B (it) Composizione oftalmica per l'uso nel mantenimento della midriasi oculare
MX9708525A (es) Derivados de vinilpirrolidinon-cefalosporina.
MX9207546A (es) Aminoesteroides para uso oftalmico

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees